Indeed, a study has shown that RBC AChE measurement might have the potential as a peripheral biomarker for diagnosis of familial Alzheimer’s and Parkinson’s disease dementia (Bawaskar et al., 2015). The gene discussed is ACHE; the disease is dementia.